MedPath

吉林省力盛制药有限公司

Ownership
-
Established
1992-08-08
Employees
-
Market Cap
-
Website
www.jlslszy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

101

NMPA:101

Drug Approvals

Ofloxacin Eye Drops

Product Name
氧氟沙星滴眼液
Approval Number
国药准字H20083317
Approval Date
Feb 3, 2023
NMPA

Fluconazole Eye Drops

Product Name
氟康唑滴眼液
Approval Number
国药准字H20083320
Approval Date
Feb 3, 2023
NMPA

Enoxacin Eye Drops

Product Name
依诺沙星滴眼液
Approval Number
国药准字H20083288
Approval Date
Feb 3, 2023
NMPA

Moxifloxacin Hydrochloride Eye Drops

Product Name
盐酸莫西沙星滴眼液
Approval Number
国药准字H20223059
Approval Date
Jan 30, 2022
NMPA

止嗽青果丸

Approval Number
国药准字Z13021685
Approval Date
Sep 22, 2020
NMPA

清瘟解毒丸

Approval Number
国药准字Z13022369
Approval Date
Sep 22, 2020
NMPA

银翘解毒丸

Approval Number
国药准字Z22024235
Approval Date
Jul 14, 2020
NMPA

景天五加颗粒

Approval Number
国药准字B20020406
Approval Date
Jul 14, 2020
NMPA

Fluocinonide Cream

Product Name
醋酸氟轻松乳膏
Approval Number
国药准字H22023826
Approval Date
Jun 12, 2020
NMPA

Compound Dexamethasone Acetate Cream

Product Name
复方醋酸地塞米松乳膏
Approval Number
国药准字H22024847
Approval Date
Jun 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.